The Role of Enhancer of Zeste Homolog 2 in Cellular Senescence
The Role of Enhancer of Zeste Homolog 2 in Cellular Senescence
批准号:
8847615
负责人:
Takahiro Ito
金额:
$4.31万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-07-01 至 2016-06-30
关键词:
AddressAgeAgingAging-Related ProcessBiological MarkersBypassCaenorhabditis elegansCardiovascular DiseasesCell AgingCellsCellular StressChromatinChromatin Remodeling FactorChromatin StructureChronic DiseaseComplexCoupledDNA DamageDataDefense MechanismsDiseaseDown-RegulationEpigenetic ProcessFibroblastsFormaldehydeGenesGenetic TranscriptionGenetically Engineered MouseGenome StabilityGoalsGrowthHealthHeterochromatinHigh-Throughput Nucleotide SequencingHistone H3HistonesHumanIndividualInterventionKnowledgeLeadLifeLongevityLysineMaintenanceMalignant NeoplasmsMediatingMelanocytic nevusMethylationMethyltransferaseMitochondriaModificationMolecularMonitorMutationNADPH OxidaseNerve DegenerationNeurodegenerative DisordersNon-Insulin-Dependent Diabetes MellitusNormal tissue morphologyOncogenesPathway interactionsPatientsPhenotypePhysiological ProcessesPlayPolycombPremature aging syndromeProcessProductionProgeriaProteinsReactive Oxygen SpeciesRegulatory ElementReportingRepressionResearchRisk FactorsRoleSeriesSignal PathwaySignal TransductionSiteStem cellsSyndromeTelomere ShorteningUp-RegulationVariantWound Healingage relatedbasebody systemcancer cellchromatin immunoprecipitationgene repressiongenome-widegenome-wide analysishistone methylationhuman EZH2 proteinhuman morbidityhuman mortalityimprovedmembernext generationnoveloverexpressionperoxisomeresearch studyresponsesenescencesingle cell analysistelomeretherapeutic targettissue repair
中文摘要
描述(由申请人提供):年龄是许多疾病的主要危险因素,包括癌症、心血管疾病、神经退行性疾病和II型糖尿病。最近的研究已经确定了决定和调节机体衰老的普遍机制,并影响所有器官系统。了解衰老的基本过程有望提供治疗靶点,以延缓许多与年龄相关的疾病的发作。新出现的证据表明,细胞衰老有助于机体衰老的生理过程。细胞衰老是指由端粒缩短和各种细胞应激引起的不可逆转的生长停滞。Polycomb group protein Enhancer of Zeste Homolog 2 (EZH2)是一种甲基转移酶,可催化组蛋白3在赖氨酸27 (H3K27me3)处的三甲基化,与调节细胞衰老有关。我研究的长期目标是了解导致衰老的分子过程。具体来说,我建议在这里进行一系列的机制实验和全基因组分析来研究EZH2调节细胞衰老的机制。目的1将使用敲低和过表达策略研究EZH2和Wnt信号通路之间的联系,Wnt信号通路是已知的细胞衰老调节因子。目的2将探讨抑制EZH2触发活性氧增加的机制。目的3将研究在EZH2下调诱导的衰老过程中引发的整体染色质结构的变化。我的研究将有助于定义表观遗传变化影响和调节细胞衰老的新机制。这一知识有望为延缓与年龄有关的疾病和延长人类健康寿命的干预措施开辟新的途径。
英文摘要
DESCRIPTION (provided by applicant): Age is a major risk factor for many diseases including cancer, cardiovascular disease, neurodegeneration, and type II diabetes. Recent research has identified universal mechanisms that determine and regulate organismal aging, and impact all organ systems. Understanding the fundamental processes of aging is expected to provide therapeutic targets to delay the onset of many age-associated diseases. Emerging evidence suggests that cellular senescence contributes to the physiological process of organismal aging. Cellular senescence refers to the irreversible growth arrest that is triggered by telomere shortening and also by a variety of cellular stresses. The Polycomb group protein Enhancer of Zeste Homolog 2 (EZH2), a methyltransferase that catalyzes the tri-methylation of histone 3 at lysine 27 (H3K27me3), has been implicated in regulating cellular senescence. The long-term objective of my research is to understand the molecular processes that contribute to senescence. Specifically, I propose here a series of mechanistic experiments and genome-wide analyses to investigate the mechanisms by which EZH2 regulates cellular senescence. Aim 1 will examine the connections between EZH2 and the Wnt signaling pathway, a known regulator of cellular senescence, using knockdown and overexpression strategies. Aim 2 will investigate the mechanism by which repression of EZH2 triggers the increase in reactive oxygen species. Aim 3 will examine the changes in global chromatin structure that are triggered during senescence induced by the downregulation of EZH2. My studies will help define novel mechanisms by which epigenetic changes impact and regulate cellular senescence. This knowledge is expected to open new avenues for interventions to delay age-associated diseases and increase human health span.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Role of Enhancer of Zeste Homolog 2 in Cellular Senescence
-
批准号:8695080
-
项目类别:
-
资助金额:$4.27万
-
财政年份:2013
-
负责人:Takahiro Ito
-
依托单位:
The Role of Enhancer of Zeste Homolog 2 in Cellular Senescence
-
批准号:8593530
-
项目类别:
-
资助金额:$4.22万
-
财政年份:2013
-
负责人:Takahiro Ito
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: